Analysis of the Effect of Trastuzumab Combined with Docetaxel on Serum Tumor Markers in the Treatment of HER-2 Positive Breast Cancer and Factors Influencing Therapeutic Efficacy.
- Resource Type
- Article
- Source
- Cancer Management & Research; Oct2021, Vol. 13, p8077-8084, 8p
- Subject
HER2 positive breast cancer TUMOR markers BIOMARKERS TRASTUZUMAB DOCETAXEL - Language
- ISSN
- 11791322